Pfizer CEO Albert Bourla said during an interview on Wednesday he’s “almost certain” that Americans will have to receive a COVID-19 vaccine dose every single year. During an MSNBC interview, Bourla was asked if people should expect to take a new COVID-19 booster annually, Bourla issued his response. “I’m almost certain about it. I say…
Pfizer CEO Is ‘Almost Certain’ Americans Will Have to Get Yearly COVID-19 Shots
Pfizer COVID-19 Vaccine Impacts Semen: Study
Pfizer’s COVID-19 vaccine leads to lower levels of semen, according to a new study. Researchers analyzed 220 samples of semen from three sperm banks in Israel, drawn from men who received two doses of the vaccine. The semen collection was scheduled seven days after receipt of the second dose. The researchers, led by Dr. Itai…
Pfizer to Buy 8.1 Percent Stake in French Vaccines Company Valneva
PARIS—U.S. healthcare giant Pfizer has agreed to invest 90.5 million euros ($95.24 million) to buy an 8.1 percent stake in French vaccines company, as the companies announced developments in their partnership to tackle the Lyme disease. Pfizer will buy the stake in Valneva, which is also working on its COVID-19 vaccine, at a price of…
‘Severely Flawed’: Cardiologist Criticizes FDA-Funded Study Suggesting Myocarditis, Pericarditis Risks from COVID-19 Vaccines
June 18, 2022
admin
AMERICABrightCCP VirusCovid NewsCOVID-19 vaccineFDAhealthHealth NewsModernaPfizerSanja VermaUSUS NewsVaccines & Safety
0 Comment
“Severely flawed” is a cardiologist’s verdict on a peer-reviewed study funded by the Food and Drug Administration (FDA) suggesting possible risks of developing myocarditis and pericarditis after getting a COVID-19 vaccine. The recent FDA study published on June 11, 2022, used health insurance databases to identify myocarditis or pericarditis hospitalizations occurring in people aged 18…
Studies Suggest Possible Link of Neuromyelitis Optica Diagnosis After COVID-19 Vaccination
June 18, 2022
admin
AmericasAsia & PacificAstrazenecaBrightCCP VirusCovid NewsCOVID-19 VaccinesEuropehealthHealth NewsModernaPfizerUSUS NewsVaccines & SafetyWorld
0 Comment
Emergent peer-reviewed studies have highlighted the occurrence of neuromyelitis optica after COVID-19 vaccinations, suggesting that the autoimmune disease may be occurring as a vaccine adverse event. The studies’ general findings indicate an occurrence of neuromyelitis optica (NMO) in healthy individuals within around two weeks after Pfizer, Moderna, and AstraZeneca vaccines. In patients already affected by…
Global-Scale COVID-19 Fraud Is Designed to Control People: Former Pfizer VP
June 16, 2022
admin
AMERICACCP VirusCOVID vaccinesdigital currencyDr. Michael YeadonExpert ViewInternationalPfizerUSUS NewsVaccines & SafetyWorld
0 Comment
Lockdowns, mask mandates, and vaccine mandates are all measures not for health, but to get people under control and move toward the ultimate goal of digital ID and digital currency, said Dr. Michael Yeadon, former Pfizer vice president and chief scientific officer for allergy and respiratory research. “In brief, I’m seeing fraud on a global…
Pfizer Stops Enrollment in Paxlovid Trial for Less Vulnerable COVID-19 Patients
Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested the drug did not reduce symptoms or hospitalizations and deaths to a statistically significant degree. Paxlovid, which consists of two different antiviral drugs—nirmatrelvir and ritonavir—is currently approved or authorized for conditional or…
Pfizer Stops Enrollment in COVID-19 Pill Trial After Drug Performs Poorly
Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested the drug did not reduce symptoms or hospitalizations and deaths to a statistically significant degree. Paxlovid, which consists of two different antiviral drugs—nirmatrelvir and ritonavir—is currently approved or authorized for conditional or…
Pfizer Stops Enrollment in COVID-19 Pill Trial After Latest Results
Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested the drug did not reduce symptoms or hospitalizations and deaths to a statistically significant degree. Paxlovid, which consists of two different antiviral drugs—nirmatrelvir and ritonavir—is currently approved or authorized for conditional or…
FDA Advisory Panel Recommends Moderna and Pfizer COVID-19 Vaccines for Babies, Toddlers
A Food and Drug Administration (FDA) advisory panel on June 15 voted to recommend the FDA give emergency authorization to the Moderna and Pfizer COVID-19 vaccines for children as young as 6 months of age. The panel unanimously voted during a virtual meeting after presentations from the companies and the FDA. The FDA has yet…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`